Justices' Diagnoses Vary in FDA Preemption Case
Attorneys and justices grappled Monday with the question of whether federal regulation of pharmaceuticals effectively immunizes drug companies from liability under state law claims, as the U.S. Supreme Court heard oral...To view the full article, register now.
Already a subscriber? Click here to view full article